Dextromethorphan Dosing for Geriatric Patients
For geriatric patients (≥65 years), administer 10 mL of dextromethorphan oral suspension (30 mg per 5 mL) every 12 hours, not exceeding 20 mL in 24 hours, which is the same adult dosing used for patients 12 years and older. 1
Dosing Algorithm
The FDA-approved dosing for dextromethorphan extended-release oral suspension is straightforward:
- Adults and children ≥12 years (including geriatric patients): 10 mL every 12 hours
- Maximum daily dose: 20 mL in 24 hours
- This delivers: 60 mg dextromethorphan per dose, 120 mg total daily 1
Critical Geriatric Considerations and Pitfalls
Exercise heightened caution in geriatric patients due to increased susceptibility to adverse effects from prolonged clearance times. 2 A case report documented a near-fatal psychotic episode in a 66-year-old slow metabolizer at CYP2D6 who inadvertently took 45 mL daily (instead of the prescribed 15 mL), highlighting the serious risks of even modest overdosing in this population. 2
Key Safety Points:
- Verify the patient understands dosing instructions: Geriatric patients may confuse tablespoons with teaspoons, leading to 3-fold overdosing 2
- Use only the provided dosing cup - do not allow substitution with household spoons 1
- Monitor for psychoactive effects: Doses above therapeutic levels can cause hallucinations, psychosis, and cognitive impairment, particularly problematic in elderly patients 2, 3
Evidence-Based Efficacy Context
While the FDA label provides clear dosing, guideline evidence suggests limited efficacy for dextromethorphan in common cold-related cough at standard doses. 4 Maximum cough reflex suppression occurs at 60 mg (the dose delivered by 10 mL of this formulation), with dose-response effects demonstrated up to this level. 4 Studies in chronic bronchitis patients aged 54-65 showed 50% reduction in cough counts at 60 mg doses. 5
The guideline notes that commonly recommended dosages are often subtherapeutic, but the 60 mg dose per administration in this formulation represents the therapeutically effective threshold. 4
Drug Interaction Warning
If the geriatric patient is taking monoamine oxidase inhibitors (MAOIs) or selective serotonin reuptake inhibitors (SSRIs), dextromethorphan poses significant risk for serotonin syndrome. 3 In such cases, alternative cough management should be strongly considered, or if dextromethorphan is used, close monitoring every 2 hours for 8 hours after each dose is recommended. 3